TDOC

Teladoc (TDOC) closed at $5.73, up 1.06% but down 10% over the past month. The telehealth provider is expected to report earnings on October 28, 2026, with projected EPS of -$0.23 (down 9.52% YoY) and revenue of $585.55 million (down 6.53% YoY). The company holds a Zacks Rank #3 (Hold) rating, with the Medical Services industry ranking in the bottom 37% of all industries.

Teladoc (TDOC) closed at $6.00, up 1.35% in the latest session, outperforming the S&P 500. However, the stock has declined 8.92% over the past month.

The company is expected to report negative EPS of -$0.23 and revenue of $585.55 million, down 6.53% year-over-year. Teladoc holds a Zacks Rank of #3 (Hold), with consensus EPS estimates unchanged over the last 30 days.

Teladoc Health is expanding its Solo connected care platform with two new AI-powered tools: SoloVitals, which uses smartphone cameras to estimate vital signs during virtual assessments, and SoloScribe, which automates clinical note generation and EHR integration. These additions aim to streamline remote care workflows for hospitals and strengthen Teladoc's position in the competitive virtual healthcare market.